{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:04:28Z","timestamp":1762491868747,"version":"build-2065373602"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To discuss the optimal renal care for critically ill patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>\n                      For hemodynamic optimization, balanced crystalloids are generally preferred over normal saline, except in patients with traumatic brain injury. A restrictive fluid management strategy may be considered in patients with advanced chronic kidney disease or those on dialysis. Norepinephrine is generally the first-line vasopressor, while the roles of vasopressin and angiotensin II are under investigation. The timing of dialysis initiation should be personalized, balancing the benefits of renal support with the risks of dialytrauma. Continuous renal replacement therapy may be preferred over conventional hemodialysis in patients with hemodynamic instability or intracranial hypertension. Optimal UF\n                      <jats:sub>NET<\/jats:sub>\n                      rates range between 1.0 and 1.5\u200aml\/kg\/h. Liberation from dialysis should be actively considered in patients showing signs of renal recovery. The risk of drug-induced acute kidney injury may be mitigated through nephrotoxin stewardship. Multidisciplinary collaboration and clinical decision support systems are key approaches. Integrating novel biomarkers and artificial intelligence into patient care is a promising strategy for achieving precision medicine.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Optimal renal care in critically ill patients is a holistic approach that considers hemodynamics, fluid therapy, administration of vasoactive agents, kidney replacement therapy, medication stewardship, and innovative advances.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mcc.0000000000001328","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:00:10Z","timestamp":1762491610000},"page":"637-645","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Optimum renal care in critically ill patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Szu-Yu","family":"Pan","sequence":"first","affiliation":[{"name":"Department of Integrated Diagnostics & Therapeutics"},{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samira","family":"Bell","sequence":"additional","affiliation":[{"name":"Division of Population Health and Genomics, School of Medicine, University of Dundee, Dundee, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"R1-20251107","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","article-title":"Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study","volume":"41","author":"Hoste","year":"2015","journal-title":"Intensive Care Med"},{"key":"R2-20251107","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40635-022-00473-4","article-title":"Pathophysiology of fluid administration in critically ill patients","volume":"10","author":"Messina","year":"2022","journal-title":"Intensive Care Med Exp"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1056\/NEJMoa1209759","article-title":"Hydroxyethyl starch or saline for fluid resuscitation in intensive care","volume":"367","author":"Myburgh","year":"2012","journal-title":"N Engl J Med"},{"key":"R5-20251107","first-page":"Cd000567","article-title":"Colloids versus crystalloids for fluid resuscitation in critically ill people","volume":"8","author":"Lewis","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2213-2600(23)00417-4","article-title":"Balanced crystalloids versus saline for critically ill patients (BEST-Living): a systematic review and individual patient data meta-analysis","volume":"12","author":"Zampieri","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00134-024-07369-9","article-title":"European Society of Intensive Care Medicine clinical practice guideline on fluid therapy in adult critically ill patients. Part 1: the choice of resuscitation fluids","volume":"50","author":"Arabi","year":"2024","journal-title":"Intensive Care Med"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.2021.11444","article-title":"Effect of slower vs faster intravenous fluid bolus rates on mortality in critically ill patients: the BaSICS Randomized Clinical Trial","volume":"326","author":"Zampieri","year":"2021","journal-title":"JAMA"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"EVIDoa2400359","DOI":"10.1056\/EVIDoa2400359","article-title":"Blood pressure targets for adults with vasodilatory shock \u2013 an individual patient data meta-analysis","volume":"4","author":"Angriman","year":"2025","journal-title":"NEJM Evid"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1056\/NEJMoa1312173","article-title":"High versus low blood-pressure target in patients with septic shock","volume":"370","author":"Asfar","year":"2014","journal-title":"N Engl J Med"},{"key":"R12-20251107","first-page":"597","article-title":"Meaning of arterio-venous PCO2 difference in circulatory shock","volume":"72","author":"Lamia","year":"2006","journal-title":"Minerva Anestesiol"},{"key":"R13-20251107","first-page":"181","article-title":"Understanding the carbon dioxide gaps","volume":"24","author":"Scheeren","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"S1528","DOI":"10.21037\/jtd.2019.07.10","article-title":"How can CO(2)-derived indices guide resuscitation in critically ill patients?","volume":"11","author":"Gavelli","year":"2019","journal-title":"J Thorac Dis"},{"key":"R15-20251107","doi-asserted-by":"crossref","first-page":"17256","DOI":"10.1038\/s41598-021-96806-6","article-title":"Central venous-to-arterial PCO(2) difference as a marker to identify fluid responsiveness in septic shock","volume":"11","author":"Nassar","year":"2021","journal-title":"Sci Rep"},{"key":"R16-20251107","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1186\/s13054-024-05156-y","article-title":"Changes in central venous-to-arterial PCO(2) difference and central venous oxygen saturation as markers to define fluid responsiveness in critically ill patients: a pot-hoc analysis of a multicenter prospective study","volume":"28","author":"Mallat","year":"2024","journal-title":"Crit Care"},{"key":"R17-20251107","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s13054-023-04714-0","article-title":"Effect on capillary refill time of volume expansion and increase of the norepinephrine dose in patients with septic shock","volume":"27","author":"Fage","year":"2023","journal-title":"Crit Care"},{"key":"R18-20251107","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bpa.2017.10.002","article-title":"The macro- and microcirculation of the kidney","volume":"31","author":"Guerci","year":"2017","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"R20-20251107","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1007\/s00134-024-07676-1","article-title":"Fluid balance neutralization secured by hemodynamic monitoring versus protocolized standard of care in patients with acute circulatory failure requiring continuous renal replacement therapy: results of the GO NEUTRAL randomized controlled trial","volume":"50","author":"Bitker","year":"2024","journal-title":"Intensive Care Med"},{"key":"R21-20251107","first-page":"542","article-title":"Hemodynamic management of acute kidney injury","volume":"30","author":"De Backer","year":"2024","journal-title":"Curr Opin Crit Care"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","article-title":"Restriction of intravenous fluid in ICU patients with septic shock","volume":"386","author":"Meyhoff","year":"2022","journal-title":"N Engl J Med"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1056\/NEJMoa2212663","article-title":"Early restrictive or liberal fluid management for sepsis-induced hypotension","volume":"388","author":"Shapiro","year":"2023","journal-title":"N Engl J Med"},{"key":"R24-20251107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s13054-024-05019-6","article-title":"Fluid management for sepsis-induced hypotension in patients with advanced chronic kidney disease: a secondary analysis of the CLOVERS trial","volume":"28","author":"Jorda","year":"2024","journal-title":"Crit Care"},{"key":"R25-20251107","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.kint.2016.02.017","article-title":"Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury","volume":"90","author":"Lankadeva","year":"2016","journal-title":"Kidney Int"},{"key":"R26-20251107","doi-asserted-by":"crossref","first-page":"e951","DOI":"10.1097\/CCM.0000000000004511","article-title":"Beneficial effects of vasopressin compared with norepinephrine on renal perfusion, oxygenation, and function in experimental septic acute kidney injury","volume":"48","author":"Okazaki","year":"2020","journal-title":"Crit Care Med"},{"key":"R27-20251107","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa067373","article-title":"Vasopressin versus norepinephrine infusion in patients with septic shock","volume":"358","author":"Russell","year":"2008","journal-title":"N Engl J Med"},{"key":"R28-20251107","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.2016.10485","article-title":"Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH Randomized Clinical Trial","volume":"316","author":"Gordon","year":"2016","journal-title":"JAMA"},{"key":"R29-20251107","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/ALN.0000000000001434","article-title":"Vasopressin versus norepinephrine in patients with vasoplegic shock after cardiac surgery: the VANCS Randomized Controlled Trial","volume":"126","author":"Hajjar","year":"2017","journal-title":"Anesthesiology"},{"key":"R30-20251107","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"R31-20251107","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ahj.2024.03.008","article-title":"Prospective randomized double-blind study to evaluate the superiority of vasopressin versus norepinephrine in the management of the patient at renal risk undergoing cardiac surgery with cardiopulmonary bypass (NOVACC trial)","volume":"272","author":"Guinot","year":"2024","journal-title":"Am Heart J"},{"key":"R32-20251107","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1603017","article-title":"Initiation strategies for renal-replacement therapy in the intensive care unit","volume":"375","author":"Gaudry","year":"2016","journal-title":"N Engl J Med"},{"key":"R33-20251107","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1056\/NEJMoa1803213","article-title":"Timing of renal-replacement therapy in patients with acute kidney injury and sepsis","volume":"379","author":"Barbar","year":"2018","journal-title":"N Engl J Med"},{"key":"R34-20251107","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa2000741","article-title":"Timing of initiation of renal-replacement therapy in acute kidney injury","volume":"383","author":"Bagshaw","year":"2020","journal-title":"N Engl J Med"},{"key":"R35-20251107","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(21)00350-0","article-title":"Comparison of two delayed strategies for renal replacement therapy initiation for severe acute kidney injury (AKIKI 2): a multicentre, open-label, randomised, controlled trial","volume":"397","author":"Gaudry","year":"2021","journal-title":"Lancet"},{"key":"R36-20251107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00134-007-0590-6","article-title":"Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure","volume":"33","author":"Bell","year":"2007","journal-title":"Intensive Care Med"},{"key":"R37-20251107","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/CCM.0000000000000042","article-title":"The association between renal replacement therapy modality and long-term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study","volume":"42","author":"Wald","year":"2014","journal-title":"Crit Care Med"},{"key":"R38-20251107","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jcrc.2017.05.002","article-title":"Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit","volume":"41","author":"Nash","year":"2017","journal-title":"J Crit Care"},{"key":"R39-20251107","first-page":"1","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R40-20251107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s40635-023-00566-8","article-title":"Precision net ultrafiltration dosing in continuous kidney replacement therapy: a practical approach","volume":"11","author":"Murugan","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"R41-20251107","doi-asserted-by":"crossref","first-page":"e195418","DOI":"10.1001\/jamanetworkopen.2019.5418","article-title":"Association of net ultrafiltration rate with mortality among critically ill adults with acute kidney injury receiving continuous venovenous hemodiafiltration: a secondary analysis of the randomized evaluation of normal vs augmented level (RENAL) of renal replacement therapy trial","volume":"2","author":"Murugan","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R42-20251107","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/ndt\/gfaa032","article-title":"Early net ultrafiltration rate and mortality in critically ill patients receiving continuous renal replacement therapy","volume":"36","author":"Naorungroj","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"R43-20251107","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ckj\/sfz179","article-title":"Net ultrafiltration rate and its impact on mortality in patients with acute kidney injury receiving continuous renal replacement therapy","volume":"14","author":"Tehranian","year":"2021","journal-title":"Clin Kidney J"},{"key":"R44-20251107","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00134-007-0754-4","article-title":"Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators","volume":"33","author":"Uchino","year":"2007","journal-title":"Intensive Care Med"},{"key":"R46-20251107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00134-007-0813-x","article-title":"Risk factors of early redialysis after weaning from postoperative acute renal replacement therapy","volume":"34","author":"Wu","year":"2008","journal-title":"Intensive Care Med"},{"key":"R47-20251107","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/ki.2011.160","article-title":"Plasma neutrophil gelatinase-associated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia","volume":"80","author":"Srisawat","year":"2011","journal-title":"Kidney Int"},{"key":"R48-20251107","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13613-022-00989-8","article-title":"Cell cycle arrest biomarkers for predicting renal recovery from acute kidney injury: a prospective validation study","volume":"12","author":"Jia","year":"2022","journal-title":"Ann Intensive Care"},{"key":"R49-20251107","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s00134-019-05919-0","article-title":"Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study","volume":"46","author":"Hoste","year":"2020","journal-title":"Intensive Care Med"},{"key":"R50-20251107","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.5858\/arpa.2021-0411-OA","article-title":"Urinary biomarkers can predict weaning from acute dialysis therapy in critically ill patients","volume":"146","author":"Pan","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"R51-20251107","doi-asserted-by":"crossref","first-page":"154929","DOI":"10.1016\/j.jcrc.2024.154929","article-title":"The furosemide stress test predicts successful discontinuation of continuous renal replacement therapy in critically ill patients with acute kidney injury","volume":"85","author":"Xu","year":"2025","journal-title":"J Crit Care"},{"key":"R52-20251107","doi-asserted-by":"crossref","first-page":"100200","DOI":"10.1016\/j.mcpdig.2025.100200","article-title":"External validation of persistent severe acute kidney injury prediction with machine learning model","volume":"3","author":"Zappal\u00e0","year":"2025","journal-title":"Mayo Clin Proc Digit Health"},{"key":"R53-20251107","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.115","article-title":"Phenotype standardization for drug-induced kidney disease","volume":"88","author":"Mehta","year":"2015","journal-title":"Kidney Int"},{"key":"R54-20251107","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ccc.2020.11.002","article-title":"Nephrotoxin stewardship","volume":"37","author":"Kane-Gill","year":"2021","journal-title":"Crit Care Clin"},{"key":"R55-20251107","first-page":"832","article-title":"Contemporary considerations for nephrotoxin stewardship: Estimating kidney function and use of novel biomarkers","volume":"7","author":"Kane-Gill","year":"2024","journal-title":"JACCP"},{"key":"R56-20251107","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/10600280221117993","article-title":"Interventions, barriers, and proposed solutions associated with the implementation of a protocol that uses clinical decision support and a stress biomarker test to identify ICU patients at high-risk for drug associated acute kidney injury","volume":"57","author":"Williams","year":"2023","journal-title":"Ann Pharmacother"},{"key":"R57-20251107","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s13054-019-2504-8","article-title":"Clinical use of [TIMP-2]\u2022[IGFBP7] biomarker testing to assess risk of acute kidney injury in critical care: guidance from an expert panel","volume":"23","author":"Guzzi","year":"2019","journal-title":"Crit Care"},{"key":"R58-20251107","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s00467-020-04898-5","article-title":"Urinary neutrophil gelatinase-associated lipocalin rules out nephrotoxic acute kidney injury in children","volume":"36","author":"Goldstein","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"R59-20251107","doi-asserted-by":"crossref","first-page":"e2430401","DOI":"10.1001\/jamanetworkopen.2024.30401","article-title":"Electronic alert systems for patients with acute kidney injury: a systematic review and meta-analysis","volume":"7","author":"Chen","year":"2024","journal-title":"JAMA Netw Open"},{"key":"R60-20251107","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1001\/jama.2024.22718","article-title":"Early, individualized recommendations for hospitalized patients with acute kidney injury: a randomized clinical trial","volume":"332","author":"Aklilu","year":"2024","journal-title":"JAMA"},{"key":"R61-20251107","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1038\/s41467-023-38532-3","article-title":"A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes","volume":"14","author":"Wilson","year":"2023","journal-title":"Nat Commun"},{"key":"R62-20251107","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/ki.2008.341","article-title":"Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery","volume":"74","author":"Koyner","year":"2008","journal-title":"Kidney Int"},{"key":"R63-20251107","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1681\/ASN.2015101177","article-title":"High level of fasting plasma proenkephalin \u2013 a predicts deterioration of kidney function and incidence of CKD","volume":"28","author":"Schulz","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R64-20251107","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1373\/clinchem.2018.288068","article-title":"Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock","volume":"64","author":"Caironi","year":"2018","journal-title":"Clin Chem"},{"key":"R65-20251107","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ekir.2018.08.006","article-title":"Proenkephalin A 119\u2013159 (Penkid) is an early biomarker of septic acute kidney injury: the Kidney in Sepsis and Septic Shock (Kid-SSS) Study","volume":"3","author":"Hollinger","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R66-20251107","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s00134-016-4670-3","article-title":"Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: the PrevAKI randomized controlled trial","volume":"43","author":"Meersch","year":"2017","journal-title":"Intensive Care Med"},{"key":"R67-20251107","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1213\/ANE.0000000000005458","article-title":"Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: the PrevAKI-Multicenter Randomized Controlled Trial","volume":"133","author":"Zarbock","year":"2021","journal-title":"Anesth Analg"},{"key":"R68-20251107","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/SLA.0000000000002485","article-title":"Biomarker-guided intervention to prevent acute kidney injury after major surgery: the prospective randomized BigpAK study","volume":"267","author":"G\u00f6cze","year":"2018","journal-title":"Ann Surg"},{"key":"R69-20251107","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/s13054-023-04641-0","article-title":"Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis","volume":"27","author":"See","year":"2023","journal-title":"Crit Care"},{"key":"R70-20251107","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.ajkd.2015.06.018","article-title":"Urinary, plasma, and serum biomarkers\u2019 utility for predicting acute kidney injury associated with cardiac surgery in adults: a meta-analysis","volume":"66","author":"Ho","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R71-20251107","doi-asserted-by":"crossref","first-page":"e016028","DOI":"10.1136\/bmjopen-2017-016028","article-title":"Optimal cut points of plasma and urine neutrophil gelatinase-associated lipocalin for the prediction of acute kidney injury among critically ill adults: retrospective determination and clinical validation of a prospective multicentre study","volume":"7","author":"Tecson","year":"2017","journal-title":"BMJ Open"},{"key":"R72-20251107","first-page":"871","article-title":"Generative AI in critical care nephrology: applications and future prospects","volume":"53","author":"Cheungpasitporn","year":"2024","journal-title":"Blood Purif"},{"key":"R73-20251107","first-page":"542","article-title":"Digital health utilities in acute kidney injury management","volume":"29","author":"Kashani","year":"2023","journal-title":"Curr Opin Crit Care"},{"key":"R74-20251107","first-page":"563","article-title":"Artificial intelligence to guide management of acute kidney injury in the ICU: a narrative review","volume":"26","author":"De Vlieger","year":"2020","journal-title":"Curr Opin Crit Care"},{"key":"R75-20251107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s12882-022-03025-w","article-title":"Artificial intelligence for the prediction of acute kidney injury during the perioperative period: systematic review and Meta-analysis of diagnostic test accuracy","volume":"23","author":"Zhang","year":"2022","journal-title":"BMC Nephrol"},{"key":"R76-20251107","doi-asserted-by":"crossref","first-page":"1050255","DOI":"10.3389\/fmed.2023.1050255","article-title":"Machine learning for acute kidney injury: changing the traditional disease prediction mode","volume":"10","author":"Yu","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R77-20251107","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1053\/j.ackd.2022.07.009","article-title":"Artificial intelligence in acute kidney injury prediction","volume":"29","author":"Bajaj","year":"2022","journal-title":"Adv Chronic Kidney Dis"},{"key":"R78-20251107","doi-asserted-by":"crossref","first-page":"2197290","DOI":"10.1080\/07853890.2023.2197290","article-title":"Unsupervised clustering identifies sub-phenotypes and reveals novel outcome predictors in patients with dialysis-requiring sepsis-associated acute kidney injury","volume":"55","author":"Lai","year":"2023","journal-title":"Ann Med"},{"key":"R79-20251107","first-page":"533","article-title":"Advances in critical care nephrology through artificial intelligence","volume":"30","author":"Cheungpasitporn","year":"2024","journal-title":"Curr Opin Crit Care"},{"key":"R80-20251107","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ajem.2017.03.036","article-title":"A review of hemodynamic monitoring techniques, methods and devices for the emergency physician","volume":"35","author":"Laher","year":"2017","journal-title":"Am J Emerg Med"},{"key":"R81-20251107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2110-5820-1-1","article-title":"Hemodynamic parameters to guide fluid therapy","volume":"1","author":"Marik","year":"2011","journal-title":"Ann Intensive Care"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001328","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T05:00:19Z","timestamp":1762491619000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000001328","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]}}}